These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 19750119)
21. Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion. Scott BR; Uomoto JM; Barry ES Headache; 2020 Mar; 60(3):526-541. PubMed ID: 31898813 [TBL] [Abstract][Full Text] [Related]
22. The point prevalence of dizziness or vertigo in migraine--and factors that influence presentation. Calhoun AH; Ford S; Pruitt AP; Fisher KG Headache; 2011 Oct; 51(9):1388-92. PubMed ID: 21797862 [TBL] [Abstract][Full Text] [Related]
23. Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management training. Holroyd KA; Cordingley GE; Pingel JD; Jerome A; Theofanous AG; Jackson DK; Leard L Headache; 1989 Mar; 29(3):148-53. PubMed ID: 2496052 [TBL] [Abstract][Full Text] [Related]
24. Low-dose propofol for the abortive treatment of pediatric migraine in the emergency department. Sheridan DC; Spiro DM; Nguyen T; Koch TK; Meckler GD Pediatr Emerg Care; 2012 Dec; 28(12):1293-6. PubMed ID: 23187986 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Blumenfeld A; Gennings C; Cady R Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151 [TBL] [Abstract][Full Text] [Related]
36. Survey on treatments for primary headaches in 13 specialized juvenile Headache Centers: The first multicenter Italian study. Toldo I; Rattin M; Perissinotto E; De Carlo D; Bolzonella B; Nosadini M; Rossi LN; Vecchio A; Simonati A; Carotenuto M; Scalas C; Sciruicchio V; Raieli V; Mazzotta G; Tozzi E; Valeriani M; Cianchetti C; Balottin U; Guidetti V; Sartori S; Battistella PA Eur J Paediatr Neurol; 2017 May; 21(3):507-521. PubMed ID: 28082014 [TBL] [Abstract][Full Text] [Related]
37. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Edwards KR; Norton J; Behnke M Headache; 2001; 41(10):976-80. PubMed ID: 11903525 [TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics and Management of Headache: A Real-Life Prospective, Observational Study From a Tertiary Care Center in Eastern India. Nayak S; Parida M; Das SB; Padhi PK; Behera M; Patil A; Khurana A; Kumar Swain S Cureus; 2020 Dec; 12(12):e12409. PubMed ID: 33409110 [TBL] [Abstract][Full Text] [Related]
39. Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy--a pilot study. Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):41-7. PubMed ID: 14971122 [TBL] [Abstract][Full Text] [Related]